N001--2008.6.24-26 Our company participated in CPhI & ICSE China 2008
    N002--2008.9.30-10.2 Our company participated in CPHI Worldwide 2008(Frankfurt, Germany) .
    N003--2009.6.23-25 Our company participated in CPhI & ICSE China 2009
    N004--2009.10.13-15 Our company participated in CPHI Worldwide 2009(Madrid, Spain).
    N005--2010.6.2-4 we participated in the Tenth CPHI China 2010 Exhibition.
    N006--Our company registered "Clofarabine injection",an anti-cancer new drug and held the clinical kick-off meeting on October 10, 2009.
    N007--Our company developed new drug " Febuxostat "and submitted to the CDE in October 2009.
    N008--My company developed new drug “Pirfenidone” and submitted to the CDE in June 2010.
    N009--My company developed new drug “Compound omeprazole capsule” and submitted to the CDE in June 2010.
 
 

The Beijing Hope International Pharmaceutical Co.,Ltd. (BHIP) is a high-tech enterprise which was approved by Beijing Municipal Science & Technology Commission(BMSTC). Main operations of the BHIP are the R&D, manufacture and sales of the drugs which are produced by chemical synthesis.

The BHIP is committed to technology innovation and established a R&D centre in Beijing Economic-Technological Development Area. The BHIP is mainly engaged in studies of synthesis and formulation of chemical drugs. The BHIP helped some Chinese and foreign pharmaceutical companies to accomplish New Drug Applications (NDA) in China.

The BHIP has a well experienced R&D team which includes over 20 researchers, most of them are professionals of some fields such as medicine, pharmaceutical and chemical synthesis etc. A production baseof pharmaceutical intermediates was establishedin Gu’an County, Hebei Province.in Tianjin , Jinan etc., The BHIP cooperated with some API GMP manufacturing enterprises in producing active pharmaceutical ingredients. In Beijing , Nanjing and Xi’an etc., The BHIP built up and kept good relations with the local famous pharmaceutical enterprises in technology cooperation.
Our aim is to share resources and benefits with our clients, our principle is honesty and fairness, we are actively exploring into the path of development.

  

    1. Development, registration and technology cooperation of active pharmaceutical ingredients(APIs) and new drugs;
    2. Development and customized services of APIs & pharmaceutical intermediates(PIs);
    3. Production and sales of APIs&PIs.

 
 
公司外景
 
办公室
 
办公室
 
实验室
 
Contact

 

Tel:
86-10-67886402
Fax:
86-10-67886402
E-mail:
apis@hopelife.cn
market@hopelife.cn